Migraine Patients Exhibit Increased Risk Of Developing Chronic Migraine With Sustained Triptan Treatment - Results From A Large-Scale Real-World Claims Analysis

被引：0
|
作者：
Mohajer, Ali [1 ]
L'Italien, Gilbert [2 ]
Harris, Linda [2 ]
Keller, Kathryn [2 ]
Dandona, Harsh [1 ]
Buse, Dawn
Lipton, Richard [3 ]
机构：
[1] QRAL Grp, New York, NY USA
[2] Biohaven Pharmaceut, New Haven, CT USA
[3] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
NEUROLOGY | 2021年 / 96卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2391
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Migraine Patients Exhibit Increased Risk Of Opioid Dependence With Sustained Triptan Treatment - Results From A Large-Scale Real-World Claims Analysis
    Harris, Linda
    Mohajer, Ali
    Dandona, Harsh
    Johnson, Audra
    Buse, Dawn
    Lipton, Richard
    L'Italien, Gilbert
    NEUROLOGY, 2021, 96 (15)
  • [2] Migraine Patients Exhibit Increased Relative Risk for Opioid Dependence with Sustained Triptan Treatment - Results from a Large-Scale Real-world Claims Analysis
    Harris, L.
    L'Italien, G. J.
    Dandona, H.
    Li, Y.
    Croop, R.
    Coric, V
    HEADACHE, 2020, 60 : 75 - 76
  • [3] Migraine Patients Exhibit Risk Of Medication Overuse Headache With Sustained Triptan Treatment - Results From A Large-Scale Real-World Claims Analysis
    Mohajer, Ali
    Harris, Linda
    Keller, Kathryn
    Dandona, Harsh
    Buse, Dawn
    Lipton, Richard
    L'Italien, Gilbert
    NEUROLOGY, 2021, 96 (15)
  • [4] Migraine Patients Exhibit Increased Relative Risk for Medication Overuse Headache (MOH) With Sustained Triptan Treatment - Results From a Large-Scale Real-World Claims Analysis
    Harris, L.
    L'Italien, G. J.
    Dandona, H.
    Croop, R.
    Coric, V
    HEADACHE, 2020, 60 : 75 - 75
  • [5] Migraine Patients Exhibit Increased Relative Risk for Medication Overuse Headache with Sustained Triptan Treatment - Results from a Real-World Claims Analysis
    Harris, Linda
    Croop, Robert
    Coric, Vladimir
    L'Italien, Gilbert
    Dandona, Harsh
    Li, Ying
    NEUROLOGY, 2020, 94 (15)
  • [6] Real-world experience with topiramate in the preventive treatment of migraine and chronic migraine: Results from a tertiary center
    Tavares, C
    Krymchantowski, AV
    Adriano, MV
    Penteado, JC
    NEUROLOGY, 2004, 62 (07) : A145 - A146
  • [7] Operationalization of Triptan Labels to Identify Migraine Patients With Cardiovascular Contraindications and Warnings Using Real-world Claims Data
    Dodick, D. W.
    Shewale, A. R.
    Lipton, R. B.
    Baum, S. J.
    Marcus, S. C.
    Silberstein, S. D.
    Pavlovic, J.
    Bennett, N. L.
    Young, W. B.
    Viswanathan, H. N.
    Doshi, J. A.
    Weintraub, H.
    HEADACHE, 2020, 60 : 77 - 78
  • [8] Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data
    Dodick, David W.
    Shewale, Anand S.
    Lipton, Richard B.
    Baum, Seth J.
    Marcus, Steven C.
    Silberstein, Stephen D.
    Pavlovic, Jelena M.
    Bennett, Nathan L.
    Young, William B.
    Viswanathan, Hema N.
    Doshi, Jalpa A.
    Weintraub, Howard
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2020, 11
  • [9] Association of migraine treatments with reduced ischemic stroke risk: Evidence from two large-scale real-world data analyses
    Jeong, Eugene
    Mogos, Mulubrhan F.
    Chen, You
    HEADACHE, 2025,
  • [10] Real-world evidence of the effectiveness and satisfaction with eptinezumab treatment in patients with chronic migraine
    Argoff, C.
    Khan, F.
    Herzog, S.
    Smith, R.
    Kotak, S.
    Sopina, L.
    Soni-Brahmbhatt, S.
    Kymes, S.
    HEADACHE, 2023, 63 : 160 - 161
12345